Colin Quinn
Associate Professor of Clinical Neurology
Director of Neuromuscular Clinical Trials, University of Pennsylvania
Neurology Department, Neuromuscular Division
Department: Neurology
Contact information
3 W. Gates
3400 Spruce St.
Philadelphia, PA 19104
3400 Spruce St.
Philadelphia, PA 19104
Office: 215-662-2625
Fax: 215-349-5579
Fax: 215-349-5579
Email:
colin.quinn@uphs.upenn.edu
colin.quinn@uphs.upenn.edu
Education:
BS (Health Studies)
Boston University, 1999.
MS (Physical Therapy)
Boston University, 2001.
MD (Medicine)
University of Virginia, 2007.
Permanent linkBS (Health Studies)
Boston University, 1999.
MS (Physical Therapy)
Boston University, 2001.
MD (Medicine)
University of Virginia, 2007.
Selected Publications
Fournier CN, Quinn CC.: The Amyotrophic Lateral Sclerosis Multidisciplinary Clinic: Broke but Not Broken. Neurology 104: e210189, Feb 2025.Austin MA, Supple GE, Carrell S, Quinn C, Elman L, Nazarian S.: Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy. JACC Clin Electrophysiol Jan 2025.
Fournier CN, Levine M, Simmons K, García-Santibáñez RC, Rowland A, Quinn CC, Ho DT, Bedlack RS, Glass JD.: ALS Motor Observational Telemedicine Objective Rasch-Built Assessment: A Quantitative Scale for the Era of Teleneurology. Neurol Clin Pract Jan 2025.
Morganroth J, Bardakjian TM, Dratch L, Quinn CC, Elman LB.: Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With SOD1-ALS. Neurol Clin Pract May 2024.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team.: Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Neurol May 2024.
Quinn C, Baer M, Amado DA, Kelley M, Elman L.: A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiol. Muscle Nerve Apr 2024.
Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA.: Disparities in Genetic Testing for Neurologic Disorders. Neurology 102: e209161, Mar 2024.
Dratch L, Bardakjian TM, Johnson K, Babaian N, Gonzalez-Alegre P, Elman L, Quinn C, Guo MH, Scherer SS, Amado DA.: The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular Clinics. Biology (Basel) 13: 93, Feb 2024.
Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA.: Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts. J Neurol Feb 2024.
Singer M, Khella S, Bird S, McIntosh P, Paudyal B, Wadhwani A, Quinn C, Karam C.: Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events. Muscle Nerve Jan 2024.